Kappa-light Chain Amyloid Overlapping Hypertrophic Cardiomyopathy With Myocardial Noncompaction | Circulation: Cardiovascular Imaging
Blood stem cell transplantation to treat cystic lung light chain deposition disease | European Respiratory Society
Cardiac Light Chain Deposition Disease Mimicking Immunoglobulin Light Chain Amyloidosis | Circulation: Cardiovascular Imaging
Light chain deposition disease involving kidney and liver in a patient with IgD myeloma | BMC Nephrology | Full Text
Prognostic impact of rapid reduction of involved free light chains in multiple myeloma patients under first-line treatment with Bendamustine, Prednisone, and Bortezomib (BPV) | SpringerLink
Serum free light chain analysis - Davids - 2010 - American Journal of Hematology - Wiley Online Library
Light-chain deposit disease
Serum levels of (A) free kappa, (B) free lambda light chains and (C)... | Download Scientific Diagram
Extraosseous myeloma of liver mimicking multifocal hepatocellular carcinoma where a distinction has to be made: two case reports | HKMJ
Intrathecal kappa free light chains as markers for multiple sclerosis | Scientific Reports
The role of free kappa and lambda light chains in the pathogenesis and treatment of inflammatory diseases - ScienceDirect
Diagnostics | Free Full-Text | The Current Role of the Heavy/Light Chain Assay in the Diagnosis, Prognosis and Monitoring of Multiple Myeloma: An Evidence-Based Approach
Frontiers | “Complimenting the Complement”: Mechanistic Insights and Opportunities for Therapeutics in Hepatocellular Carcinoma
Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology
Cureus | Nivolumab-Induced Crescentic Immunoglobulin A Nephropathy With Henoch-Schonlein Purpura Features in a Patient Diagnosed With Hepatocellular Carcinoma | Article
Cancers | Free Full-Text | Immunoglobulin M Paraproteinaemias
FREE LIGHT CHAINS (SERUM) | LABCORP OKLAHOMA INC.
Kappa Light Chain Monoclonal Antibody (TB28-2), FITC (11-9970-42)
Diagnostic and mechanistic implications of serum free light chains, albumin and alpha-fetoprotein in hepatocellular carcinoma | British Journal of Cancer
The pathogenesis of renal injury and treatment in light chain deposition disease | Journal of Translational Medicine | Full Text
Light Chain-Associated Renal Disorders: Practice Essentials, Pathophysiology, Etiology
Frontiers | H-TEX-mediated signaling between hepatocellular carcinoma cells and macrophages and exosome-targeted therapy for hepatocellular carcinoma
Cancers | Free Full-Text | Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial
Living With - HealthTree for Myeloma
